Hypertension Diagnostics, Inc.
HDII
OTC PK
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -81.81% | 10.22% | -12.77% | -410.90% | -334.72% |
| Total Depreciation and Amortization | 131.21% | 397.33% | -- | -- | 22,433.33% |
| Total Amortization of Deferred Charges | 742.18% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -486.21% | -329.63% | -195.44% | 73.38% | 123.73% |
| Change in Net Operating Assets | 262.68% | 310.90% | 1,041.22% | 846.91% | -939.41% |
| Cash from Operations | 69.34% | -32.27% | -1,336.55% | -498.78% | -512.53% |
| Capital Expenditure | 60.33% | 56.91% | -1,670.85% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 494.12% | 356.25% | 300.00% | -- |
| Cash from Investing | 92.05% | 91.57% | -252.06% | -204.40% | -- |
| Total Debt Issued | -90.07% | 121.66% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.78% | 111.38% | -- | 2,991.00% | 1,398.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.41% | 88.86% | -195.37% | -126.49% | -264.16% |
